Mediclinic International PLC Holding(s) in Company (2484C)

TIDMMDC

RNS Number : 2484C

Mediclinic International PLC

12 April 2017

Mediclinic International plc

(Incorporated in England and Wales)

Company Number 8338604

LSE Share Code: MDC

JSE Share Code: MEI

NSX Share Code: MEP

ISIN: GB00B8HX8Z88

LEI: 2138002S5BSBIZTD5I60

12 April 2017

Notification of Major Interest in Mediclinic International plc shares

 
 1. Identity of the issuer or                                     Mediclinic International 
  the underlying issuer                                                                plc 
  of existing shares to which 
  voting rights are 
  attached: 
-----------------------------------------------------------  ----------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
------------------------------------------------------------------------------------------ 
 An acquisition or disposal of voting rights                                x 
------------------------------------------------------------  ---------------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
------------------------------------------------------------  ---------------------------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
------------------------------------------------------------  ---------------------------- 
 An event changing the breakdown of voting rights 
------------------------------------------------------------  ---------------------------- 
 Other (please 
  specify): 
----------------------------------------------------------    ---------------------------- 
 3. Full name of person(s)                                    Coronation Asset Management 
  subject to the                                                        (Pty) Ltd 
  notification obligation: 
-----------------------------------------------------------  ----------------------------- 
 4. Full name of shareholder(s)                                           N/A 
  (if different from 3.): 
-----------------------------------------------------------  ----------------------------- 
 5. Date of the transaction                                          10 April 2017 
  and date on 
  which the threshold is 
  crossed or 
  reached: 
-----------------------------------------------------------  ----------------------------- 
 6. Date on which issuer                                             11 April 2017 
  notified: 
-----------------------------------------------------------  ----------------------------- 
 7. Threshold(s) that is/are 
  crossed or 
  reached:                                                                 5% 
-----------------------------------------------------------  ----------------------------- 
 
 
 
 8. Notified details: 
---------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares 
---------------------------------------------------------------------------------------------------------------------- 
 Class/type     Situation previous                   Resulting situation after the 
  of             to the triggering                    triggering transaction 
  shares         transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
-------------  -----------------------------------  ------------------------------------------------------------------ 
                Number             Number            Number          Number of                % of voting 
                of                  of                of shares       voting                   rights 
                Shares              Voting                            rights 
                                    Rights 
-------------  -----------------  ----------------  --------------  -----------------------  ------------------------- 
                                                     Direct          Direct     Indirect      Direct        Indirect 
-------------      -------------    ------------    --------------  ---------  ------------  ------------  ----------- 
                36 852             36 852            37 677          37 677 
 GB00B8HX8Z88    189                189               189            189                      5.11% 
               -----------------  ----------------  --------------  ---------  ------------  ------------  ----------- 
 
 
 B: Qualifying Financial Instruments 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of            Expiration       Exercise/                         Number of voting           % of voting 
 financial           date             Conversion                        rights that                rights 
 instrument                           Period                            may be 
                                                                        acquired if 
                                                                        the 
                                                                        instrument 
                                                                        is 
                                                                        exercised/ 
                                                                        converted. 
-----------------  ---------------  --------------------------------  -------------------------  --------------------- 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of          Exercise         Expiration      Exercise/         Number of voting           % of voting 
 financial         price           date            Conversion         rights instrument          rights 
 instrument                                        period             refers to 
---------------  ---------------  --------------  ----------------  -------------------------  ----------------------- 
                                                                                                Nominal       Delta 
---------------  ---------------  --------------  ----------------  -------------------------  ------------  --------- 
 
 
 Total (A+B+C) 
---------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                               Percentage of voting rights 
----------------------------------------------------  ---------------------------------------------------------------- 
 37 677 189                                            5.11% 
----------------------------------------------------  ---------------------------------------------------------------- 
 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
------------------------------------------------------------------- 
 
 
 Proxy Voting: 
------------------------------------------------------------------- 
 10. Name of the proxy holder:          Coronation Asset Management 
                                                          (Pty) Ltd 
-------------------------------------  ---------------------------- 
 11. Number of voting rights proxy 
  holder will cease 
  to hold: 
-------------------------------------  ---------------------------- 
 12. Date on which proxy holder will 
  cease to hold 
  voting rights: 
-------------------------------------  ---------------------------- 
 
 
  13. Additional information: 
-------------------------------------  ---------------------------- 
 14. Contact name:                             Jamie Rowland 
-------------------------------------  ---------------------------- 
 15. Contact telephone number:                [phone] 
-------------------------------------  ---------------------------- 
 
 

Mediclinic's primary listing is on the Main Market of the LSE, with secondary listings on the JSE in South

Africa and on the NSX in Namibia.

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

Website: www.mediclinic.com

Corporate broker: Morgan Stanley & Co International plc

JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

For further information please contact:

Mediclinic International plc

James Arnold, Head of Investor Relations

[e-mail]

Capita Company Secretarial Services Limited

Victoria Dalby

[phone]

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUAANRBSASAAR

(END) Dow Jones Newswires

April 12, 2017 02:30 ET (06:30 GMT)